Maastricht University Medical Centre; Afdeling Klinische Farmacie en Toxicologie

Maastricht 6229HX

0 studies enrolling now · 1 studies all time

What they study most

Non-Small-Cell Lung Carcinoma

Studies at this site

• A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment — Completed